Hopp til innhold
NHI.no
Annonse

Psoriasis, årsaker: Utløsende faktorer

Pasienter med psoriasis kan oppleve at sykdommen tilsynelatende starter på grunn av ytre hendelser, som for eksempel i forbindelse med fysiske eller psykiske påkjenninger. Hos pasienter med anlegg for psoriasis er det ofte slike hendelser som utløser tilstanden, og som senere kan føre til nye oppblomstringer. Vi regner ikke dette som årsaken, men kun en utløsende faktor som gjør at tilstanden bryter ut akkurat da.

Annonse

Infeksjoner som for eksempel halsbetennelse med streptokokker, kan også føre til utbrudd av sykdom. Noen merker at kulde forverrer, og mange har merket at sol og varme lindrer sykdommen.

Det finnes også noen medikamenter som kan forverre eller utløse psoriasis. Dette gjelder blant annet en type hjertemedisiner som kalles betablokkere. Det gjelder også litium, som brukes i behandlingen av bipolare lidelser, og klorokin som brukes mot malaria. Dersom du skal begynne med en ny medisin, bør du alltid fortelle legen din at du har psoriasis.

Dette dokumentet er basert på det profesjonelle dokumentet Psoriasis . Referanselisten for dette dokumentet vises nedenfor

  1. Weigle N, McBane S. Psoriasis. Am Fam Physician 2013; 87: 626-33. PubMed
  2. Coates LC, Moverley AR, McParland L, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386(10012):2489-98. PubMed
  3. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013 Jun;168(6):1303-10. PMID: 23374051. PubMed
  4. Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet. 2021 Apr 3;397(10281):1301-1315. PMID: 33812489. PubMed
  5. Chen T-L, Lee L-L, Huang H-K, et al. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease A Systematic Review and Meta-analysis. JAMA Dermatol 2021. pmid:34851364 PubMed
  6. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496-509. PubMed
  7. Roubille C, Richer V, Starnino T, et al. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. J Rheumatol 2015; 42: 1767-80. pmid:26178281 PubMed
  8. Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. PMID: 29928910. PubMed
  9. Jabbar-Lopez ZK, Wu KC, Reynolds NJ. Newer agents for psoriasis in adults. BMJ. 2014 Jul 9;349:g4026. doi: 10.1136/bmj.g4026. PMID: 25008099 PubMed
  10. Ryan C, Menter A. Psoriasis and cardiovascular disorders. G Ital Dermatol Venereol 2012; 147: 189-202. pmid:22481581 PubMed
  11. Burden-Teh E, Phillips RC, Thomas KS, et al . A systematic review of diagnostic criteria for psoriasis in adults and children: evidence from studies with a primary aim to develop or validate diagnostic criteria. Br J Dermatol 2018; 178: 1035-1043. PubMed
  12. Pogorelov D, Tschesche A, Balakirski G, Hofmann SC. Generalized Pustular Psoriasis of Pregnancy Successfully Treated With Certolizumab Pegol: A Case Report and Literature Review. Cureus. 2024 May 7;16(5):e59832. PMID: 38846233. PubMed
  13. Langenbruch A, Radtke MA, Krensel M, et al.. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. . Br J Dermatol. 2014; 171: 1123-1128. pmid:25040629 PubMed
  14. Mason AR, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2013. pmid:23543539. PubMed
  15. Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev 2016. pmid:26915340. PubMed
  16. Samarasekera EJ, Sawyer L, Wonderling D, et al . Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. British Journal of Dermatology 2013; 168: 954-67. pmid:23413913. PubMed
  17. Wang C, Lin A. Efficacy of topical calcineurin inhibitors in psoriasis. J Cutan Med Surg. 2014;18(1):8-14. PubMed
  18. NFDV: Veiledende anbefalinger for systemisk behandling av psoriasis vulgaris, versjon 2, mars 2023, siden lest 23.03.24 www.legeforeningen.no
  19. Montaudié H, Sbidian E, Paul C, et al . Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol 2011; 2: 12-18. pmid:21388454. PubMed
  20. Maza A, Montaudie H, Sbidian E, et al. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Euro Acad Dermatol Venereol. 2011;25(suppl 2):19-27. PMID: 21388455. PubMed
  21. Dupire G, Droitcourt C, Hughes C, et al . Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2019. pmid:30835819. PubMed
  22. European Dermatology Forum. Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris. Last updated 07/2020. siden lest 08.04.2024 www.edf.one
  23. Leisner MZ, Riis JL, Schwartz BS et al. Psoriasis and Risk of Mental Disorders in Denmark. JAMA Dermatol 2019.0039 pmid:31066861 PubMed
  24. Balda A, Wani I, Roohi TF, et al. Psoriasis and skin cancer - Is there a link? Int Immunopharmacol. 2023 Aug;121:110464. PMID: 37390565. PubMed
  25. Li X, Andersen KM, Chang H-Y, et al. Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis. Ann Rheum Dis 2019. pmid:31672774 PubMed
  26. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61: 1373-8. pmid:19790120 PubMed
  27. Zhao SS, Yiu ZZN, Barton A, Bowes J. Association of Lipid-Lowering Drugs With Risk of Psoriasis A Mendelian Randomization Study. JAMA Dermatol 2023. pmid:36696131 PubMed
  28. Philipp S, Wolk K, Kreutzer S, et al. The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder. Expert Opin Ther Targets 2006;10:817-831. PubMed
  29. Lapolla W, Yentzer BA, Bagel J, et al. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64:936-949. PubMed
  30. Sbidian E, Chaimani A, Afach S, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No.: CD011535. The Cochrane Library
  31. Meng Y, Dongmei L, Yanbin P, et al. Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clin Exp Dermatol 2014; 39: 696-707. pmid:25039593.
  32. Meng Y, Dongmei L, Yanbin P, et al . Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clin Exp Dermatol 2014; 39: 696-707. pmid:25039593. PubMed
  33. Langley RG, Elewski BE, Lebwohl MN, et al. Secukinumab in plaque psoriasis--results of two phase 3 trials. N Engl J Med. 2014;371:326-338. PubMed
  34. Pouplard C, Brenaut E, Horreau C, et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol. 2013;27(suppl 3):36-46. PMID: 23845151 PubMed
  35. Trafford AM, Parisi R, Kontopantelis E, et al. Association of Psoriasis With the Risk of Developing or Dying of Cancer A Systematic Review and Meta-analysis. JAMA Dermatol 2019. pmid:31617868 PubMed
  36. Ahlehoff O, Skov L, Gislason G, et al . Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med 2013; 273: 197-204. pmid:22963528. PubMed
  37. Crowley JJ, Weinberg JM, Wu JJ et al. Treatment of Nail Psoriasis. JAMA Dermatol 2015; 151(1): 87-94. pmid:25471223 PubMed
  38. Horn EJ, Fox KM, Patel V, et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57(6):957-62. PubMed
  39. Smith CH, Jabbar-Lopez ZK, Yiu ZZ, et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177(3):628-36. PubMed
  40. Giet G, Senterre Y, Lebas E, et al . Le phénomène de Köbner en dermatologie Köbner's phenomenon in dermatology.. Rev Med Liege 2021; 76: 651-656. pmid:34477334. PubMed
  41. Ko SH, Chi CC, Yeh ML, et al. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev. 2019 Jul 16;7(7):CD011972. PMID: 31309536. PubMed
Annonse
Annonse